...
首页> 外文期刊>The American Journal of the Medical Sciences >Predictors of positive immunofixation testing in patients with acute kidney injury
【24h】

Predictors of positive immunofixation testing in patients with acute kidney injury

机译:急性肾损伤患者免疫固定试验阳性的预测因素

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Introduction: Acute kidney injury may be the presenting manifestation of multiple myeloma, although optimal use of immunofixation testing in this setting is incompletely defined. The authors attempted to determine clinical and laboratory predictors of positive immunofixation testing in patients with acute kidney injury. PATIENTS AND Methods: The authors did a retrospective study of hospitalized patients with acute kidney injury who had immunofixation studies done. Various clinical and laboratory variables that may be predictive of the presence of multiple myeloma were evaluated and correlations with immunofixation test results determined. Results: One hundred twenty-eight patients were studied. Thirteen had a monoclonal paraprotein detected by immunofixation testing (positive result). Patients with positive testing had higher total, ionized and corrected calcium levels, although the median total calcium in immunofixation-positive patients was normal at 9.7 mg/dL. Patients with positive testing also had lower hemoglobin and platelet counts. An anion gap of <7 mmol/L and total protein-albumin gap >4 g/dL were also associated with positive results. Conclusions: In patients with acute kidney injury, relatively higher total, ionized and corrected calcium levels and lower hemoglobin and platelet counts may predict the presence of a monoclonal paraprotein. An anion gap of <7 mmol/L and total protein-albumin gap >4 g/dL may also be predictors. The metabolic consequences of acute kidney injury may attenuate some of these abnormalities as well. These findings may help guide optimal use of immunofixation testing and hence help potentially identify patients who may have multiple myeloma.
机译:简介:急性肾损伤可能是多发性骨髓瘤的表现形式,尽管在这种情况下免疫固定测试的最佳使用尚不完全明确。作者试图确定急性肾脏损伤患者中免疫固定试验阳性的临床和实验室预测指标。患者与方法:作者对接受免疫固定研究的住院急性肾损伤患者进行了回顾性研究。评价了可预测多发性骨髓瘤存在的各种临床和实验室变量,并确定了与免疫固定测试结果的相关性。结果:研究了128例患者。十三例通过免疫固定试验检测到了单克隆副蛋白(阳性结果)。尽管免疫固定阳性患者的总钙中位数为9.7 mg / dL正常,但接受阳性测试的患者的总钙,离子化和校正钙水平较高。测试阳性的患者血红蛋白和血小板计数也较低。阴离子间隙<7 mmol / L和总蛋白-白蛋白间隙> 4 g / dL也与阳性结果相关。结论:在急性肾损伤患者中,相对较高的总钙,离子钙和校正钙水平以及较低的血红蛋白和血小板计数可以预示单克隆副蛋白的存在。阴离子间隙<7 mmol / L和总蛋白-白蛋白间隙> 4 g / dL也可能是预测因素。急性肾损伤的代谢后果也可以减轻其中一些异常。这些发现可能有助于指导免疫固定测试的最佳使用,从而有助于潜在地识别可能患有多发性骨髓瘤的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号